Market Overview

UPDATE: Stifel Upgrades IMAX

Related IMAX
Imax's CEO Talks About The Company's Biggest Deal In 50 Years
15 Biggest Mid-Day Gainers For Thursday
Solid box office revenue amid 'sequelitis virus' (Seeking Alpha)

In a report released Monday, Stifel analyst Benjamin Mogil upgraded IMAX (NYSE: IMAX) from Hold to Buy with a $32 price target.

Analysts at Stifel have previously tracked IMAX's EBITDA per screen declines due to cost troubles limiting operating leverage and low trends in box office. Stifel now anticipates high JRSA margin expansion in result to expected change operating leverage and EBITDA per screen growth.

Mogil claimed IMAX China concerns are overblown because of CJ CGV and Wanda conducting most of the installations for 2014, 2015 and anticipates accelerated installs in 2016 with the next Avatar.

Stifel's $32 price target is given a 2015 estimated EBITDA multiple of 13.8x minority interest.

Latest Ratings for IMAX

Jul 2016Roth CapitalAssumesBuy
Mar 2016BenchmarkMaintainsBuy
Feb 2016WedbushUpgradesNeutralOutperform

View More Analyst Ratings for IMAX
View the Latest Analyst Ratings

Posted-In: Benjamin Mogil StifelUpgrades Price Target Analyst Ratings


Related Articles (IMAX)

View Comments and Join the Discussion!